t2t_test
The Type Ingestion process in FEGA focuses on integrating standardized study metadata into the federated system. It captures essential information such as study title, description, design, and identifiers. This ensures consistency and improves data discoverability across participating nodes. The harmonized metadata supports efficient search, retrieval, and reuse of genomic and phenotypic data. Overall, it plays a key role in enabling FAIR (Findable, Accessible, Interoperable, Reusable) data principles within the FEGA ecosystem.
- 23/09/2025
- 1 sample
- DAC: EGAC00000000011
- Technology: unspecified
DUO:0000025 version: 2021-02-23
time limit on use
This data use modifier indicates that use is approved for a specific number of months.
BC Cancer, part of the Provincial Health Services Authority - Data Access Policy
Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS50000000428 | Whole Genome Sequencing |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Quality Report |
Located in
i
|
|---|---|---|---|---|
| EGAF50000105254 | fna | 3.2 GB |
Federated EGA
|
|
| 1 File (3.2 GB) | ||||